{"id":"https://openalex.org/W3040569835","doi":"https://doi.org/10.1016/j.vascn.2020.106895","title":"Quantifying drug-induced structural toxicity in hepatocytes and cardiomyocytes derived from hiPSCs using a deep learning method","display_name":"Quantifying drug-induced structural toxicity in hepatocytes and cardiomyocytes derived from hiPSCs using a deep learning method","publication_year":2020,"publication_date":"2020-07-03","ids":{"openalex":"https://openalex.org/W3040569835","doi":"https://doi.org/10.1016/j.vascn.2020.106895","mag":"3040569835","pmid":"https://pubmed.ncbi.nlm.nih.gov/32629158"},"language":"en","primary_location":{"id":"doi:10.1016/j.vascn.2020.106895","doi":"https://doi.org/10.1016/j.vascn.2020.106895","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.vascn.2020.106895","pdf_url":"https://www.sciencedirect.com/science/article/pii/S1056871920302240/pdf","source":{"id":"https://openalex.org/S89571363","display_name":"Journal of Pharmacological and Toxicological Methods","issn_l":"1056-8719","issn":["1056-8719","1873-488X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmacological and Toxicological Methods","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.sciencedirect.com/science/article/pii/S1056871920302240/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5084779220","display_name":"Mahnaz Maddah","orcid":"https://orcid.org/0000-0002-9837-6000","observed_orcids":["https://orcid.org/0000-0002-9837-6000"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mahnaz Maddah","raw_affiliation_strings":["Dana Solutions, Palo Alto, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana Solutions, Palo Alto, CA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080823164","display_name":"Mohammad A. Mandegar","orcid":"https://orcid.org/0000-0002-5323-7891","observed_orcids":["https://orcid.org/0000-0002-5323-7891"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mohammad A. Mandegar","raw_affiliation_strings":["Tenaya Therapeutics, South San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tenaya Therapeutics, South San Francisco, CA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019127833","display_name":"Keri Dame","orcid":"https://orcid.org/0000-0002-1772-7076","observed_orcids":["https://orcid.org/0000-0002-1772-7076"]},"institutions":[{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I1333606569","display_name":"Center for Drug Evaluation and Research","ror":"https://ror.org/00yf3tm42","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Keri Dame","raw_affiliation_strings":["Division of Applied Regulatory Science, Office of Translational Science, Office of Clinical Pharmacology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Applied Regulatory Science, Office of Translational Science, Office of Clinical Pharmacology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA","institution_ids":["https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019292504","display_name":"Francis Grafton","orcid":"https://orcid.org/0000-0001-8578-1632","observed_orcids":["https://orcid.org/0000-0001-8578-1632"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Francis Grafton","raw_affiliation_strings":["Tenaya Therapeutics, South San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tenaya Therapeutics, South San Francisco, CA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002865530","display_name":"Kevin E. Loewke","orcid":"https://orcid.org/0000-0001-7182-4742","observed_orcids":["https://orcid.org/0000-0001-7182-4742"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kevin Loewke","raw_affiliation_strings":["Dana Solutions, Palo Alto, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana Solutions, Palo Alto, CA, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5014077740","display_name":"Alexandre J. S. Ribeiro","orcid":"https://orcid.org/0000-0002-1552-8778","observed_orcids":["https://orcid.org/0000-0002-1552-8778","https://orcid.org/0009-0004-3421-2527"]},"institutions":[{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I1333606569","display_name":"Center for Drug Evaluation and Research","ror":"https://ror.org/00yf3tm42","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Alexandre J.S. Ribeiro","raw_affiliation_strings":["Division of Applied Regulatory Science, Office of Translational Science, Office of Clinical Pharmacology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA. Electronic address: alexandre.ribeiro@fda.hhs.gov","Division of Applied Regulatory Science, Office of Translational Science, Office of Clinical Pharmacology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Applied Regulatory Science, Office of Translational Science, Office of Clinical Pharmacology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA. Electronic address: alexandre.ribeiro@fda.hhs.gov","institution_ids":["https://openalex.org/I1320320070","https://openalex.org/I1333606569"]},{"raw_affiliation_string":"Division of Applied Regulatory Science, Office of Translational Science, Office of Clinical Pharmacology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA","institution_ids":["https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5014077740"],"corresponding_institution_ids":["https://openalex.org/I1320320070","https://openalex.org/I1333606569"],"apc_list":{"value":3500,"currency":"USD","value_usd":3500},"apc_paid":{"value":3500,"currency":"USD","value_usd":3500},"fwci":2.1272,"has_fulltext":true,"cited_by_count":35,"citation_normalized_percentile":{"value":0.88008721,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"105","issue":null,"first_page":"106895","last_page":"106895"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12859","display_name":"Cell Image Analysis Techniques","score":0.7128999829292297,"subfield":{"id":"https://openalex.org/subfields/1304","display_name":"Biophysics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12859","display_name":"Cell Image Analysis Techniques","score":0.7128999829292297,"subfield":{"id":"https://openalex.org/subfields/1304","display_name":"Biophysics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11465","display_name":"Drug-Induced Hepatotoxicity and Protection","score":0.19359999895095825,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12281","display_name":"Animal testing and alternatives","score":0.026799999177455902,"subfield":{"id":"https://openalex.org/subfields/3404","display_name":"Small Animals"},"field":{"id":"https://openalex.org/fields/34","display_name":"Veterinary"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hepatotoxicity","display_name":"hepatotoxicity","score":0.8080000281333923},{"id":"https://openalex.org/keywords/cardiotoxicity","display_name":"cardiotoxicity","score":0.9940000176429749},{"id":"https://openalex.org/keywords/cardiomyocytes","display_name":"cardiomyocytes","score":0.8270000219345093},{"id":"https://openalex.org/keywords/deep-learning-image-analysis","display_name":"deep learning image analysis","score":0.7940000295639038},{"id":"https://openalex.org/keywords/cyp3a4","display_name":"CYP3A4","score":0.8560000061988831},{"id":"https://openalex.org/keywords/tamoxifen","display_name":"tamoxifen","score":0.8270000219345093},{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":0.996999979019165},{"id":"https://openalex.org/keywords/erlotinib","display_name":"erlotinib","score":0.8270000219345093},{"id":"https://openalex.org/keywords/sorafenib","display_name":"sorafenib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/live-cell-imaging","display_name":"live-cell imaging","score":0.4830000102519989},{"id":"https://openalex.org/keywords/cytotoxicity-screening","display_name":"cytotoxicity screening","score":0.7680000066757202}],"concepts":[{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.6951591968536377},{"id":"https://openalex.org/C107459253","wikidata":"https://www.wikidata.org/wiki/Q674925","display_name":"Induced pluripotent stem cell","level":4,"score":0.4882226288318634},{"id":"https://openalex.org/C2781303535","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin","level":3,"score":0.48494866490364075},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.45586469769477844},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4480045437812805},{"id":"https://openalex.org/C39133596","wikidata":"https://www.wikidata.org/wiki/Q5165683","display_name":"Contractility","level":2,"score":0.434402734041214},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4046654999256134},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.39445173740386963},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.38050737977027893},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.19677704572677612},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.11103954911231995},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0},{"id":"https://openalex.org/C145103041","wikidata":"https://www.wikidata.org/wiki/Q1151519","display_name":"Embryonic stem cell","level":3,"score":0.0},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000069347","descriptor_name":"Erlotinib Hydrochloride","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000077157","descriptor_name":"Sorafenib","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000077321","descriptor_name":"Deep Learning","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D001681","descriptor_name":"Biological Assay","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D002478","descriptor_name":"Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013629","descriptor_name":"Tamoxifen","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D018675","descriptor_name":"Toxicity Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D022781","descriptor_name":"Hepatocytes","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D032383","descriptor_name":"Myocytes, Cardiac","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D057026","descriptor_name":"Induced Pluripotent Stem Cells","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D064420","descriptor_name":"Drug-Related Side Effects and Adverse Reactions","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D066126","descriptor_name":"Cardiotoxicity","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.vascn.2020.106895","doi":"https://doi.org/10.1016/j.vascn.2020.106895","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.vascn.2020.106895","pdf_url":"https://www.sciencedirect.com/science/article/pii/S1056871920302240/pdf","source":{"id":"https://openalex.org/S89571363","display_name":"Journal of Pharmacological and Toxicological Methods","issn_l":"1056-8719","issn":["1056-8719","1873-488X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmacological and Toxicological Methods","raw_type":"journal-article"},{"id":"pmid:32629158","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32629158","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of pharmacological and toxicological methods","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1016/j.vascn.2020.106895","doi":"https://doi.org/10.1016/j.vascn.2020.106895","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.vascn.2020.106895","pdf_url":"https://www.sciencedirect.com/science/article/pii/S1056871920302240/pdf","source":{"id":"https://openalex.org/S89571363","display_name":"Journal of Pharmacological and Toxicological Methods","issn_l":"1056-8719","issn":["1056-8719","1873-488X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmacological and Toxicological Methods","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9391000270843506,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G8226228672","display_name":null,"funder_award_id":"RFA-FD-19-002","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320332163","display_name":"U.S. Food and Drug Administration","ror":"https://ror.org/034xvzb47"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3040569835.pdf","grobid_xml":"https://content.openalex.org/works/W3040569835.grobid-xml"},"referenced_works_count":86,"referenced_works":["https://openalex.org/W1530577558","https://openalex.org/W1591504141","https://openalex.org/W1869171504","https://openalex.org/W1907511822","https://openalex.org/W1969455207","https://openalex.org/W1971378456","https://openalex.org/W1974588788","https://openalex.org/W1975396117","https://openalex.org/W1989324891","https://openalex.org/W1990392771","https://openalex.org/W1993047099","https://openalex.org/W1997218466","https://openalex.org/W2004542031","https://openalex.org/W2010427019","https://openalex.org/W2017134832","https://openalex.org/W2024636644","https://openalex.org/W2026441415","https://openalex.org/W2027665912","https://openalex.org/W2030583987","https://openalex.org/W2035396567","https://openalex.org/W2044038482","https://openalex.org/W2049573968","https://openalex.org/W2051789180","https://openalex.org/W2059628989","https://openalex.org/W2068643393","https://openalex.org/W2083369014","https://openalex.org/W2084290677","https://openalex.org/W2091557317","https://openalex.org/W2100073637","https://openalex.org/W2104418746","https://openalex.org/W2108614024","https://openalex.org/W2109823050","https://openalex.org/W2111923125","https://openalex.org/W2113134500","https://openalex.org/W2119126373","https://openalex.org/W2123132907","https://openalex.org/W2126124449","https://openalex.org/W2132917470","https://openalex.org/W2141455139","https://openalex.org/W2144916644","https://openalex.org/W2152352541","https://openalex.org/W2156472837","https://openalex.org/W2157394282","https://openalex.org/W2158966376","https://openalex.org/W2164681558","https://openalex.org/W2166535515","https://openalex.org/W2183389629","https://openalex.org/W2189155589","https://openalex.org/W2201192914","https://openalex.org/W2218551807","https://openalex.org/W2260219453","https://openalex.org/W2317055602","https://openalex.org/W2334788811","https://openalex.org/W2345645905","https://openalex.org/W2467851095","https://openalex.org/W2509640388","https://openalex.org/W2554504883","https://openalex.org/W2558581266","https://openalex.org/W2581780532","https://openalex.org/W2584427437","https://openalex.org/W2587938050","https://openalex.org/W2604319603","https://openalex.org/W2612118981","https://openalex.org/W2617613555","https://openalex.org/W2622826443","https://openalex.org/W2751625431","https://openalex.org/W2754006450","https://openalex.org/W2788132769","https://openalex.org/W2803317672","https://openalex.org/W2804029005","https://openalex.org/W2804666587","https://openalex.org/W2806461776","https://openalex.org/W2887280559","https://openalex.org/W2899441429","https://openalex.org/W2925321055","https://openalex.org/W2944807100","https://openalex.org/W2946901414","https://openalex.org/W2954996726","https://openalex.org/W2959505001","https://openalex.org/W2962968776","https://openalex.org/W2966204485","https://openalex.org/W2968908300","https://openalex.org/W3014276173","https://openalex.org/W3015790912","https://openalex.org/W4211245332","https://openalex.org/W6631621261"],"related_works":["https://openalex.org/W3189803229","https://openalex.org/W2158966376","https://openalex.org/W2810563415","https://openalex.org/W3027646407","https://openalex.org/W4317542747","https://openalex.org/W1985439976","https://openalex.org/W4384627044","https://openalex.org/W4400136093","https://openalex.org/W2766275521","https://openalex.org/W4413368425"],"abstract_inverted_index":{"Cardiac":[0],"and":[1,13,73,112,132,150,195,219],"hepatic":[2],"toxicity":[3,182,215],"result":[4],"from":[5,32,76,100],"induced":[6,78,191],"disruption":[7],"of":[8,11,23,59,65,86,97,102,114,121,127,135,148,162,214],"the":[9,21,57,84,87,95,110,115,146,199,206],"functioning":[10],"cardiomyocytes":[12,74],"hepatocytes,":[14],"respectively,":[15],"which":[16,168,185],"is":[17],"tightly":[18],"related":[19,159],"to":[20,91,144,160],"organization":[22,96],"their":[24],"subcellular":[25],"structures.":[26],"Cellular":[27],"structure":[28],"can":[29,204],"be":[30,48],"analyzed":[31],"microscopy":[33],"imaging":[34],"data.":[35],"However,":[36],"subtle":[37,207],"or":[38,104],"complex":[39],"structural":[40,68,181],"changes":[41,69,209],"that":[42,202,210],"are":[43,211],"not":[44],"easily":[45],"perceived":[46],"may":[47],"missed":[49],"by":[50,123,192],"conventional":[51],"image-analysis":[52],"techniques.":[53],"Here":[54],"we":[55,141],"report":[56],"evaluation":[58],"PhenoTox,":[60],"an":[61],"image-based":[62],"deep-learning":[63],"method":[64,90,116],"quantifying":[66],"drug-induced":[67],"using":[70,129],"human":[71,77],"hepatocytes":[72,218],"derived":[75],"pluripotent":[79],"stem":[80],"cells.":[81,106],"We":[82,107],"assessed":[83],"ability":[85],"deep":[88],"learning":[89],"detect":[92],"variations":[93],"in":[94,183,216],"cellular":[98],"structures":[99],"images":[101],"fixed":[103],"live":[105],"also":[108],"evaluated":[109],"power":[111],"sensitivity":[113,172],"for":[117,137,167],"detecting":[118],"toxic":[119],"effects":[120,147],"drugs":[122],"conducting":[124],"a":[125,174],"set":[126],"experiments":[128],"known":[130],"toxicants":[131],"other":[133],"methods":[134],"screening":[136],"cytotoxic":[138],"effects.":[139],"Moreover,":[140],"used":[142],"PhenoTox":[143,156,179,203],"characterize":[145],"tamoxifen":[149],"doxorubicin-which":[151],"cause":[152],"liver":[153],"toxicity-on":[154],"hepatocytes.":[155],"revealed":[157],"differences":[158],"loss":[161],"cytochrome":[163],"P450":[164],"3A4":[165],"activity,":[166],"it":[169],"showed":[170],"greater":[171],"than":[173],"caspase":[175],"3/7":[176],"assay.":[177],"Finally,":[178],"detected":[180],"cardiomyocytes,":[184],"was":[186],"correlated":[187],"with":[188],"contractility":[189],"defects":[190],"doxorubicin,":[193],"erlotinib,":[194],"sorafenib.":[196],"Taken":[197],"together,":[198],"results":[200],"demonstrated":[201],"capture":[205],"morphological":[208],"early":[212],"signs":[213],"both":[217],"cardiomyocytes.":[220]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":8},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2020-07-10T00:00:00"}